Recent

% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • thegreen_o thegreen_o Dec 10, 2012 2:14 PM Flag

    Seeking " James Stocklaser That Said BUY ACAD, Now Says CLSN is STRONG BUY. /// link ////

     

    Seeking " James Stocklaser That Said BUY ACAD, Now Says CLSN is STRONG BUY. /// link ////
    Seeking Alpha
    ARTICLE NAME "A Reasoned Case For Celsion's ThermoDox"
    December 10, 2012
    By: James Stocklasar Thomas Jr
    I think it's common knowledge that any therapy that promotes progression free recurrence is a global billion dollar plus market opportunity. As others have pointed out, with ThermoDox targeting multiple medical indications, the long-term market opportunity is a billion dollar multiple. Seeing how Celsion has already extended the ThermoDox footprint into the European and Asia markets along with the rest of the world including the United States, I hesitate to imagine how high on phase III success the company's share price could rise as events unfold. Therefore, priced in the $7's/share and taking every risk into account, I conclude based on my three-prong study that Celsion is a VERY STRONG BUY.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ARNA
1.81-0.10(-5.24%)Jun 24 4:00 PMEDT